Boehringer Ingelheim registers Phase 1 bioequivalence trial for vicadrostat/empagliflozinWeekly roundup, 4 itemsBoehringer Ingelheimempagliflozin
Boehringer Ingelheim registers Phase Ib/II trial pairing obrixtamig, pumitamig in SCLCTrial updateBioNTech SEBoehringer Ingelheim
Boehringer Ingelheim registers Phase 3 VERANDA-IIM trial of nerandomilast in myositisTrial updateBoehringer Ingelheimnerandomilast
Boehringer Ingelheim registers Phase I trial of immunotherapy BI 3822971 in solid tumorsTrial updateBoehringer Ingelheim
Boehringer Ingelheim posts completed bioequivalence trial of two pramipexole tablet formulationsTrial updateBoehringer Ingelheimpramipexole
Boehringer Ingelheim registers Phase Ib/II trial pairing obrixtamig with Zai Lab's ZL-1310 in SCLCTrial updateBoehringer IngelheimZai Lab (Shanghai) Co., Ltd.
Boehringer Ingelheim registers Phase I mass balance trial for BI 3034701Trial updateBoehringer Ingelheim
Sign inSign in